-+ 0.00%
-+ 0.00%
-+ 0.00%
Codexis reports 3- to 4-fold higher siRNA potency in human cell study
Share
Listen to the news
Codexis reports 3- to 4-fold higher siRNA potency in human cell study
  • Codexis on Nov. 9, 2026, announced results already presented at TIDES Europe showing improved siRNA potency in human liver cell models.
  • Initial findings from an ongoing study showed greater potency for material made using ECO Synthesis than identical siRNA produced through traditional chemical methods.
  • Manufacturing data showed consistent product quality at larger scale with shorter production times, supporting the platform’s progress toward commercial adoption.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090600PRIMZONEFULLFEED9873099) on November 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending